Please ensure Javascript is enabled for purposes of website accessibility

High-quality , affordable generic products with excellent service

Viona Pharmaceuticals is a fast-growing generic pharmaceutical company with its headquarters in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Zydus Lifesciences Limited, a fully integrated, global healthcare provider. Viona is marketing and distributing a strong portfolio of oral solids and topicals and has a vast number of products in the development pipeline, which we are excited to introduce to the market in due time! To see the products that we have already introduced into the market, please see our list of products.

Viona has built a team of experienced and committed professionals in all aspects of the business and we have ambitious growth plans for our company.

Our mission is to provide our customers with high quality, affordable generic products with an excellent service level.


May 2018

Viona Incorporated

May 2019

Viona launches Metronidazole Tablets, USP 250mg & 500mg

July 2019

Viona launches Voriconazole Tablets 50mg & 200mg

September 2019

Viona launches Doxycycline Hyclate Tablets, USP 100mg

December 2019

Viona launches Memantine Hydrochloride Tablets, USP 5mg & 10mg and Metformin Hydrochloride Tablets Extended-Release Tablets, USP 750mg

January 2020

Viona launches Ranolazine Extended-Release Tablets 500mg & 1,000mg

July 2020

Viona launches Acyclovir Ointment, USP 5% and Desonide Cream 0.05%

September 2020

Viona launches Betamethasone Dipropionate Ointment, USP 0.05% and Fluocinonide Cream, USP 0.1%

October 2020

Viona launches Nystatin Ointment, USP 100,000 units Per Gram

November 2020

Viona launches Desoximetasone Ointment, USP 0.025%


January 2021

Viona launches Triamterene and Hydrochlorothiazide Capsules, USP 37.5 mg/25 mg, Nystatin and Triamcinolone Acetonide Ointment USP, Desoximetasone Cream, USP 0.25%,  and Acyclovir Capsules, USP 200 mg




March 2021

Viona launches Felbamate Tablets, USP 400 mg & 600 mg, and Clindamycin Phosphate Topical Solution, USP 1%



March 2022

Viona launches Doxycycline Hyclate Capsules, USP 50 mg & 200 mg


April 2022

Viona launches Levofloxacin Tablets, USP 250 mg, 500 mg & 750 mg



June 2022

Viona launches Adapalene and Benzoyl Peroxide Topical Gel, 0.3% / 2.5%



July 2022

Viona launches Modafinil Tablets, USP 100 mg & 200 mg

August 2022

Viona launches Aripiprazole Orally Disintegrating Tablets, USP 10 mg & 15 mg

September 2022

Viona launches Zonisamide Capsules, USP 25 mg, 50 mg & 100 mg

October 2022

Viona launches Clobetasol Propionate Lotion, 0.05%

December 2022

Viona launches Tizanidine Tablets, USP 2 mg & 4 mg

January 2023

Viona launches Mirtazapine Orally Disintegrating Tablets, USP 15 mg, 30 mg & 45 mg

February 2023

Viona launches Bisoprolol Fumarate Tablets, USP 5 mg & 10 mg

March 2023

Viona launches Acyclovir Cream, 5%

May 2023

Viona launches Tavaborole Topical Solution, 5%

July 2023

Viona launches Ivermectin Cream, 1%

July 2023

Viona launches Loperamide Hydrochloride Capsules, USP 2 mg


July 2023

Viona launches Sucralfate Tablets, USP 1 gram

July 2023

Viona launches Febuxostat Tablets, 40 mg and 80 mg

August 2023

Viona launches Metronidazole Topical Cream, 0.75%



October 2023

Viona launches Acetazolamide Tablets, USP 125 mg and 250 mg

March 2024

Viona launches Clindamycin Phosphate Gel, USP 1%

April 2024

Viona launches Bisoprolol Fumarate and Hydrochlorothiazide, USP 2.5 mg/6.25 mg, 5 mg/6.25 mg and 10 mg/6.25 mg